PHI with Retrospondylosis
How does this condition affect your private health insurance?
While "Retrospondylose" is not a standard medical diagnosis, interpreting it as a descriptive term for a spinal degenerative condition, it refers to changes affecting the vertebral column. This condition, commonly known as spondylosis or spinal osteoarthritis, involves the wearing down of vertebrae, intervertebral discs, and facet joints. It leads to the formation of bone spurs (osteophytes), disc dehydration, and narrowing of the spinal canal or nerve root exits. Symptoms typically include chronic back pain, stiffness, reduced flexibility, and potentially neurological issues like numbness, tingling, or weakness if nerves are compressed. It’s primarily age-related but can be influenced by genetics and mechanical stress.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 40%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to months for acute symptomatic episodes, often developing insidiously over years.
Duration of Illness (Lifetime)
Chronic, progressive condition, often lifelong with periods of exacerbation and remission.
Cost of Treatment (Initial)
Hundreds to thousands of USD for diagnosis, medication, and initial physical therapy.
Cost of Treatment (Lifetime)
Tens of thousands to hundreds of thousands of USD, potentially including ongoing therapy, medications, and surgical interventions.
Mortality Rate
Very low, indirect only through severe complications such as myelopathy causing respiratory compromise (<0.1%).
Risk of Secondary Damages
Moderate to high (50-80%) for chronic pain and functional limitations; lower (10-30%) for significant nerve compression (radiculopathy/myelopathy) requiring intervention.
Probability of Full Recovery
Low (5-10%) for complete reversal of structural changes and symptoms; however, good symptomatic control is often achievable (70-90%) with appropriate management.
Underlying Disease Risk
Moderate (30-50%) for co-existing age-related musculoskeletal conditions like osteoarthritis in other joints; lower for specific systemic inflammatory or metabolic diseases.